ChemBriefAntares Therapeutics tackles brand-new protein pockets
Antares Therapeutics secured $177 million in Series A funding to develop small-molecule drugs targeting novel protein pockets, founded by former Scorpion Therapeutics executives after Eli Lilly acquir
cen · 2026-10-12 00:00